Amygdala responses to quetiapine XR and citalopram treatment in major depression: the role of 5‐HTTLPR‐S/Lg polymorphisms
ConclusionsThese preliminary data suggest that pharmacological mechanisms and genetics need to be considered in the development of neuroimaging markers for the evaluation of antidepressant treatments. Copyright © 2016 John Wiley & Sons, Ltd.
Source: Human Psychopharmacology: Clinical and Experimental - Category: Psychiatry Authors: Rajamannar Ramasubbu, Ashley Burgess, Ismael Gaxiola‐Valdez, Filomeno Cortese, Darren Clark, Anne Kemp, Bradley Goodyear, Glenda Macqueen, N. Torben Bech‐Hansen, Jane Foster, Vaibhav A. Diwadkar Tags: Research Article Source Type: research
More News: Brain | Celexa | Citalopram | Depression | Drugs & Pharmacology | Genetics | Neurology | Psychiatry | Seroquel